[The Tenovofir trial in Cameroun. Analysis of the controversial positions and proposal for an ethical alternative].
Munday
Félicien
F
Centre de Bioéthique, Ecole de Santé Publique, Université de Kinshasa, RDCongo. felicienmun@yahoo.fr
Lubangi
Ghislain
G
Mukandu
Félicien
F
Leyens
Stéphane
S
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002163:Cameroon; D026689:Ethical Analysis; D028781:Ethical Relativism; D026724:Ethical Review; D032984:Ethics, Research; D015658:HIV Infections / Q000517:prevention & control*; D006805:Human Experimentation / Q000941:ethics*; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use*; D000068698:Tenofovir
D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine